-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Vicarious Surgical (NYSE:RBOT) Vs. Cadre (NYSE:CDRE) Head to Head Comparison
Vicarious Surgical (NYSE:RBOT) Vs. Cadre (NYSE:CDRE) Head to Head Comparison
Vicarious Surgical (NYSE:RBOT – Get Rating) and Cadre (NYSE:CDRE – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.
Earnings and Valuation
This table compares Vicarious Surgical and Cadre's gross revenue, earnings per share and valuation.
Get Vicarious Surgical alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Vicarious Surgical | N/A | N/A | -$35.21 million | $0.71 | 2.79 |
Cadre | $427.29 million | 1.88 | $12.66 million | $0.08 | 268.66 |
Cadre has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Vicarious Surgical has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.Profitability
This table compares Vicarious Surgical and Cadre's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Vicarious Surgical | N/A | -68.56% | -45.62% |
Cadre | 0.80% | 3.86% | 1.36% |
Analyst Recommendations
This is a breakdown of current ratings for Vicarious Surgical and Cadre, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Vicarious Surgical | 0 | 1 | 1 | 0 | 2.50 |
Cadre | 0 | 0 | 4 | 0 | 3.00 |
Vicarious Surgical currently has a consensus target price of $6.00, indicating a potential upside of 203.03%. Cadre has a consensus target price of $32.80, indicating a potential upside of 52.63%. Given Vicarious Surgical's higher possible upside, equities analysts clearly believe Vicarious Surgical is more favorable than Cadre.
Institutional & Insider Ownership
42.8% of Vicarious Surgical shares are held by institutional investors. Comparatively, 34.1% of Cadre shares are held by institutional investors. 52.5% of Vicarious Surgical shares are held by company insiders. Comparatively, 52.9% of Cadre shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Cadre beats Vicarious Surgical on 10 of the 13 factors compared between the two stocks.
About Vicarious Surgical
(Get Rating)
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
About Cadre
(Get Rating)
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
Vicarious Surgical (NYSE:RBOT – Get Rating) and Cadre (NYSE:CDRE – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.
Surgical(NYSE:RBOT-GET Rating)和Cadre(NYSE:CDRE-GET Rating)都是小盘医疗公司,但哪只股票更好?我们将根据两家公司的盈利能力、分析师建议、股息、机构所有权、收益、风险和估值来比较它们的实力。
Earnings and Valuation
收益和估值
This table compares Vicarious Surgical and Cadre's gross revenue, earnings per share and valuation.
这张表格比较了代理外科公司和Cadre公司的总收入、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Vicarious Surgical | N/A | N/A | -$35.21 million | $0.71 | 2.79 |
Cadre | $427.29 million | 1.88 | $12.66 million | $0.08 | 268.66 |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
代替性外科 | 不适用 | 不适用 | -3,521万元 | $0.71 | 2.79 |
干部 | 4.2729亿美元 | 1.88 | 1266万美元 | $0.08 | 268.66 |
Cadre has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.
Cadre的收入和收入比Surgary更高。该公司目前的市盈率低于Cadre,这表明它目前是两只股票中价格更实惠的一只。
Volatility and Risk
波动性和风险
Profitability
盈利能力
This table compares Vicarious Surgical and Cadre's net margins, return on equity and return on assets.
此表比较了代理外科和Cadre的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Vicarious Surgical | N/A | -68.56% | -45.62% |
Cadre | 0.80% | 3.86% | 1.36% |
净利润率 | 股本回报率 | 资产回报率 | |
代替性外科 | 不适用 | -68.56% | -45.62% |
干部 | 0.80% | 3.86% | 1.36% |
Analyst Recommendations
分析师建议
This is a breakdown of current ratings for Vicarious Surgical and Cadre, as reported by MarketBeat.
这是MarketBeat报道的《替代外科》和《干部》的当前收视率。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Vicarious Surgical | 0 | 1 | 1 | 0 | 2.50 |
Cadre | 0 | 0 | 4 | 0 | 3.00 |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
代替性外科 | 0 | 1 | 1 | 0 | 2.50 |
干部 | 0 | 0 | 4 | 0 | 3.00 |
Vicarious Surgical currently has a consensus target price of $6.00, indicating a potential upside of 203.03%. Cadre has a consensus target price of $32.80, indicating a potential upside of 52.63%. Given Vicarious Surgical's higher possible upside, equities analysts clearly believe Vicarious Surgical is more favorable than Cadre.
目前,该公司的普遍目标价为6.00美元,潜在上涨幅度为203.03%。Cadre的一致目标价为32.80美元,表明潜在上行空间为52.63%。考虑到替代外科公司更有可能的上行空间,股票分析师显然认为,替代外科公司比Cadre更有利。
Institutional & Insider Ownership
机构与内部人持股
42.8% of Vicarious Surgical shares are held by institutional investors. Comparatively, 34.1% of Cadre shares are held by institutional investors. 52.5% of Vicarious Surgical shares are held by company insiders. Comparatively, 52.9% of Cadre shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
代理外科公司42.8%的股份由机构投资者持有。相比之下,34.1%的干部股份由机构投资者持有。该公司52.5%的股份由公司内部人士持有。相比之下,52.9%的干部股份由公司内部人士持有。强大的机构持股表明,大型基金管理公司、对冲基金和捐赠基金相信,一家公司的长期表现将好于大盘。
Summary
摘要
Cadre beats Vicarious Surgical on 10 of the 13 factors compared between the two stocks.
在两只股票比较的13个因素中,Cadre有10个胜过了替补外科。
About Vicarious Surgical
关于代谢性外科
(Get Rating)
(获取评级)
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
该公司是美国的一家机器人技术公司。该公司专注于开发和商业化维多利亚系统,这是一种单切口手术机器人,可以虚拟地将外科医生运送到患者体内进行微创手术。该公司成立于2014年,总部设在马萨诸塞州的沃尔瑟姆。
About Cadre
关于干部
(Get Rating)
(获取评级)
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.
Cadre Holdings,Inc.制造和分销安全和生存能力设备,为美国和世界各地的危险或生命威胁情况下的用户提供保护。该公司在产品和分销两个领域开展业务。该公司主要提供防弹衣产品,如Safarland和Protech Tactical品牌的可隐藏、修正和战术装甲;针对炸弹安全技术人员的救生服、遥控车辆、专用工具、爆炸传感器、配件和车辆减爆座椅;防弹服;包括安全带和配件在内的值班装备;以及其他保护和执法设备,包括通信装备、法医和调查产品、枪支清洗解决方案和人群控制产品。该公司还提供第三方产品,如制服、眼镜、靴子、枪支和弹药。它为州和地方执法、消防和救援、爆炸物处理技术人员、紧急医疗技术人员、渔业和野生动物执法和惩戒部门等急救人员以及包括美国国务院、美国国防部、美国内政部、美国司法部、美国国土安全部、美国惩教部和各种外国政府机构在内的联邦机构提供服务。该公司成立于1964年,总部设在佛罗里达州杰克逊维尔。
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《替代外科日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收对替代外科及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧